Tuesday, 02 January 2024 12:17 GMT

Paypoint Plc : Director/PDMR Shareholding


(MENAFN- GlobeNewsWire - Nasdaq) 1 September 2025

PayPoint Plc

(the "Company")

PDMR Transaction

The Company announces that it has been notified that on 27 August 2025, Rob Harding, Chief Finance Officer, transferred 1,350 ordinary shares of 1/3 pence each in the Company (''Ordinary Shares'') held by him to an individual account (''ISA'') held in his name. This transfer was effected by the sale of 1,359 Ordinary Shares at a price of £7.28 per Ordinary Share and the repurchase of 1,350 Ordinary Shares at a price of £7.23 per Ordinary Share.

The notification of Dealing Form required in accordance with UK MAR is set out below.
Enquiries:

PayPoint Plc
Phil Higgins, on behalf of Indigo Corporate Secretary Limited, Company Secretary
+44 (0)07701061533

Steve O'Neill, Corporate Affairs and Marketing Director
+44 (0)7919488066

LEI: 5493004YKWI8U0GDD138

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Robert Harding
2. Reason for the notification
a) Position/status PDMR
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name PayPoint Plc
b) LEI 5493004YKWI8U0GDD138
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1/3 pence
ISIN: GB00B02QND93
b) Nature of the transaction
  • Sale of Ordinary Shares
  • Purchase of Ordinary Shares
  • c) Prices and volumes
  • Sale
    • Price: £7.28
    • Volume: 1,359
  • Purchase
    • Price: £7.23
    • Volume: 1,350
  • d) Aggregated information N/A
    e) Date of the transaction 27 August 2025
    f) Place of the transaction Outside of a trading venue

    MENAFN01092025004107003653ID1110002161

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

    Search